Rexahn Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch REXN and buy or sell other stocks, ETFs, and their options commission-free!

About REXN

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. 

CEO
George Magrath, III, MD
CEOGeorge Magrath, III, MD
Employees
18
Employees18
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
2018
Founded2018
Employees
18
Employees18

REXN Key Statistics

Market cap
81.46M
Market cap81.46M
Price-Earnings ratio
-0.48
Price-Earnings ratio-0.48
Dividend yield
—
Dividend yield—
Average volume
210.88K
Average volume210.88K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$2.18
52 Week high$2.18
52 Week low
$0.65
52 Week low$0.65

People also own

Based on the portfolios of people who own REXN. This list is generated using Robinhood data, and it’s not a recommendation.
Ocugen, Inc
Inpixon
GE
22nd Century Group
Verastem
IGC Pharma
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.